Skip to content
EN

Back to the catalog

4dmoleculartherapeutics.com
rss2American English

4DMT

4DMT | Powering The Future Of Genetic Medicines · 4dmoleculartherapeutics.com · American English

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.

rss2 wordpress content atom dc sy

Open the feed

https://4dmoleculartherapeutics.com/feed/

Last post
Sep 11, 2026
Posts in 24 h · 7 days · 30 days
0 · 0 · 1
Our last check
Answering
Served from
United States
Site title
4DMT | Powering The Future Of Genetic Medicines
Text score at discovery
329
Format
rss2
Features in the feed
content, atom, dc, sy
Community
wordpress

Posts

What our queue read from this feed. Open one to read it here, or go to the site that published it.

  1. A Strategic Shift for Gene Therapies: Manufacturing and Market Size Take Centre Stage
    Sep 11, 2026 · original
    August 24, 2026 | Pharmaceutical Technology The post A Strategic Shift for Gene Therapies: Manufacturing and Market Size Take Centre Stage first appeared on 4DMT .
  2. 4DMT Targets Global Retina Market with Long-lasting Genetic Treatment
    Aug 12, 2026 · original
    June 17, 2026 | RBC Capital Markets The post 4DMT Targets Global Retina Market with Long-lasting Genetic Treatment first appeared on 4DMT .
  3. 4D-150 Gene Therapy Reduces Treatment Burden in Wet AMD
    Aug 12, 2026 · original
    August 11, 2026 | Healio The post 4D-150 Gene Therapy Reduces Treatment Burden in Wet AMD first appeared on 4DMT .
  4. 4DMT’s 2-year PRISM Data Show Durable Treatment Burden Reduction with 4D-150 in Wet AMD
    Aug 12, 2026 · original
    July 23, 2026 | Ophthalmology Times The post 4DMT’s 2-year PRISM Data Show Durable Treatment Burden Reduction with 4D-150 in Wet AMD first appeared on 4DMT .
  5. ASRS 2026: 4D-150 Gene Therapy Shows Sustained Treatment-burden Reduction in Wet AMD at 2 years
    Aug 12, 2026 · original
    July 22, 2026 | Modern Retina The post ASRS 2026: 4D-150 Gene Therapy Shows Sustained Treatment-burden Reduction in Wet AMD at 2 years first appeared on 4DMT .
  6. Dramatic Results Seen With Gene Therapy for Age-Related Macular Degeneration
    Aug 12, 2026 · original
    July 20, 2026 | MedPage Today The post Dramatic Results Seen With Gene Therapy for Age-Related Macular Degeneration first appeared on 4DMT .
  7. 4DMT Completes Enrollment in 4FRONT-2, Global Phase 3 Trial of 4D-150 in Wet AMD
    Aug 12, 2026 · original
    June 30, 2026 | Ophthalmology Times The post 4DMT Completes Enrollment in 4FRONT-2, Global Phase 3 Trial of 4D-150 in Wet AMD first appeared on 4DMT .
  8. 4DMT Completes Enrollment in Second Phase 3 Trial of 4D-150 for Wet AMD
    Aug 12, 2026 · original
    June 29, 2026 | Eyewire News The post 4DMT Completes Enrollment in Second Phase 3 Trial of 4D-150 for Wet AMD first appeared on 4DMT .
  9. The Onyx Life Sciences Report: Companies we’re watching in 2026
    Apr 1, 2026 · original
    February/March Edition | Fortune The post The Onyx Life Sciences Report: Companies we’re watching in 2026 first appeared on 4DMT .
  10. Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation
    Apr 1, 2026 · original
    February 6, 2026 | Scrip The post Scrip Asks… What Does 2026 Hold For Biopharma? Part 4: R&D Innovation first appeared on 4DMT .

Discovered by the rss-feed-index crawler, which checks each feed at most once a month.

Same record as JSON: https://api.agentalog.com/api/feeds/fd_4dmoleculartherapeutics_com_02ffa488529dcf64. More from this site: 4dmoleculartherapeutics.com in the Feeds tab.